In this study, we demonstrated that a high CDK6 expression status may promote lymph node metastasis and that a high LRP1B expression status inhibits lymph node metastasis in patients with EJA. The gene discussed is CDK6; the disease is metastatic malignant neoplasm in the lymph nodes.